ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

SNG Synairgen Plc

4.675
0.00 (0.00%)
Last Updated: 08:00:27
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Synairgen Plc LSE:SNG London Ordinary Share GB00B0381Z20 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 4.675 4.36 4.99 - 32,693 08:00:27
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 0 -17.65M -0.0876 -0.53 9.41M
Synairgen Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker SNG. The last closing price for Synairgen was 4.68p. Over the last year, Synairgen shares have traded in a share price range of 3.65p to 10.62p.

Synairgen currently has 201,374,975 shares in issue. The market capitalisation of Synairgen is £9.41 million. Synairgen has a price to earnings ratio (PE ratio) of -0.53.

Synairgen Share Discussion Threads

Showing 2876 to 2897 of 99175 messages
Chat Pages: Latest  127  126  125  124  123  122  121  120  119  118  117  116  Older
DateSubjectAuthorDiscuss
08/4/2020
11:41
Nice to see... looks like placing shares are all sold. Could go swiftly up now.
festario
08/4/2020
11:20
Who knows!!
bmnsa
08/4/2020
11:15
anybody could comment on today's sudden rise?

combination of the following

1 articles on SNG in various media during the weekend
2 the serial seller is finally out
3 NCYT profit takers have come here
4 possible leak?

any offers?

the patient investor
08/4/2020
11:13
Quite so, Nobby. I am a strong supporter of off label compassionate use particularly where there is reasonable expectation for the toxicity profile and good potential for benefit. I would put inhaled IFN beta top of that list followed by antiIL6R/IL6 and Remdesivir. Nothing to lose, IMO.
I think hydroxychloroquine is a red herring and the anti HIV drugs have been clearly shown to be ineffective and trialling those drugs again in the UK questionable. And that is being polite.

freedosh
08/4/2020
11:07
It could be given off label on compassionate grounds so he would know he got drug if indeed this did happen. If you are not in one of the trial centres, you would not be part of the trial.
nobbygnome
08/4/2020
11:05
Bought more early on today,(by chance):))
Sometimes we can get it right.
If it dips somewhat will be getting even more.

bmnsa
08/4/2020
11:04
Next move up will be sharp
imjustdandy
08/4/2020
11:01
This won't be sub 60p very much longer.
imjustdandy
08/4/2020
10:59
Seriously impressed how quick the trolls activate.
adman50
08/4/2020
10:52
50K buy just gone through. May be just may be.
rafboy
08/4/2020
10:44
Posted on LSE:
certainly plenty of authoritative interferon Advocates:

wetdream
08/4/2020
10:40
Apologies if already posted (article today from international business times).
jules1958
08/4/2020
10:37
which seller langland?
fatnacker
08/4/2020
10:35
https://youtu.be/RFjvmThY4wUCome on let's tw...... ag....
bloomberg2
08/4/2020
10:34
It may just be that the seller of the last few days has stopped or finished.
langland
08/4/2020
10:32
that's a big move, somethings afoot.
fatnacker
08/4/2020
10:28
The doctor treating Boris...very interesting...

Previously, Dr Leach was Clinical Director for Acute Medicine from 2009-18. In the GSTT and Medway Foundation Trust (MFT) support collaboration he was an Associate Medical Director at MFT from 2015-18.
Dr Leach is on the European Specialist Registers for General (Internal), Respiratory and Critical Care Medicine and has extensive experience as a general and respiratory physician contributing to both high dependency and intensive care medicine. He has sub-specialty interests in COPD, asthma, cough, respiratory failure, sarcoidosis, multiple co-morbidity conditions and critical care medicine.

likya123
08/4/2020
10:27
>> tpi

LOL worth a tick up!

nobbygnome
08/4/2020
10:27
Ah it's the punters from ncyt investing profits in the Right place
nick9013
08/4/2020
10:18
Chart pattern beginning to repeat?
Fingers crossed.

wetdream
08/4/2020
10:17
Timbo - good point on the shelf life.

The FinnCap noted stockpile sales could be $3 billion and they used Tamiflu as an example. I always saw this as a one-off. Now if they could sell $1 billion a year to governments to maintain those stockpiles that's interesting.

pdt
08/4/2020
10:15
Raft - I concur
coley15
Chat Pages: Latest  127  126  125  124  123  122  121  120  119  118  117  116  Older

Your Recent History

Delayed Upgrade Clock